David S. McKinsey
David S. McKinsey publishes mostly in Epidemiology, Infectious Diseases and Emergency Medicine, on topics such as Fungal Infections and Studies, Antifungal resistance and susceptibility and Nail Diseases and Treatments.
- World rank
- #1,144,362 of 7,710,434 ranked researchers
- Rank in United States
- #368,759 of 1,627,098
- Works
- 58
- Citations
- 3.9k
- Citations per work
- 67.7
What does David S. McKinsey research?
David S. McKinsey's work is mostly in Medicine (58%), Immunology and Microbiology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3458.4%
- Medicine3458.4%
- Everything else2339.2%
- Life Sciences12.4%
- 1Epidemiology26% of their works
- 2Infectious Diseases23% of their works
- 3Emergency Medicine4% of their works
- 4Surgery4% of their works
- 5Public Health, Environmental and Occupational Health2% of their works
- 6Applied Microbiology and Biotechnology2% of their works
Research topics
- Fungal Infections and Studies
- Antifungal resistance and susceptibility
- Nail Diseases and Treatments
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV/AIDS Research and Interventions
- HIV-related health complications and treatments
- Antibiotic Use and Resistance
- HIV/AIDS drug development and treatment
Which keywords describe David S. McKinsey's research?
The keywords of their largest research topics: Antifungal Therapy, Epidemiology, Immunocompromised Patients, Antiretroviral Therapy, Cryptococcal Disease, Histoplasmosis, Candidiasis and Invasive Fungal Infections.
- Integrase Inhibitors
- Antibiotic Resistance
- Cardiovascular Disease
- Pneumonia
- HIV Transmission
- Drug Resistance
- HIV Infection
- Invasive Fungal Infections
- Histoplasmosis
- Antiretroviral Therapy
- Epidemiology
- Antifungal Therapy
- Immunocompromised Patients
- Cryptococcal Disease
- Candidiasis
- Diagnosis
- Dermatophytes
- Onychomycosis
- Pneumocystis
- Preexposure Prophylaxis
- Inflammation
- Antimicrobial Stewardship
- Nucleoside Analogues
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Antifungal Therapy503 topics
- Epidemiology394 topics
- Immunocompromised Patients272 topics
- Antiretroviral Therapy234 topics
- Cryptococcal Disease221 topic
- Histoplasmosis221 topic
- Candidiasis201 topic
- Invasive Fungal Infections201 topic
- Diagnosis152 topics
- HIV Infection92 topics
- Dermatophytes81 topic
- Drug Resistance82 topics
- Onychomycosis81 topic
- HIV Transmission71 topic
- Pneumocystis71 topic
- Pneumonia71 topic
- Preexposure Prophylaxis71 topic
- Cardiovascular Disease51 topic
- Inflammation51 topic
- Antibiotic Resistance41 topic
- Antimicrobial Stewardship41 topic
- Integrase Inhibitors41 topic
- Nucleoside Analogues41 topic
Where does David S. McKinsey work?
David S. McKinsey's main affiliation in the publication record is Infectious Disease Consultants, United States.
How many publications and citations does David S. McKinsey have?
OpenAlex counts 58 works and 3,924 citations for David S. McKinsey, an h-index of 23, ranking #1,144,362 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David S. McKinsey. Posts are plain text and can be reported.